Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03634462 · ClinicalTrials.gov registry record · NA

Complete Decongestive Therapy With Negative Pressure for Lipedema and Lymphedema Therapy

A NA study, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT03634462 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03634462, a NA study, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

This study is designed to investigate the therapy outcomes from routine physical therapy in persons with lipedema and secondary limb lymphedema. Complete decongestive therapy (CDT) is a common conservative treatment to optimize lymphatic functioning using exercise, compression, lymphatic stimulation and skin care. PhysioTouch is a gentle graded negative pressure device designed to enhance lymphatic stimulation that is used by the skilled therapist in conjunction with hands on techniques of tissue mobilization for enhanced clearance of lymph stasis in persons with lymphedema. This study will investigate the conservative treatment impact in patients with lipedema and lower extremity lymphedema using this conservative available technique.

Interventions

  • OTHER CDT with graded negative pressure

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-01-15
Est. Completion 2020-02-28
Phase NA

What the Registry Record Tells You About NCT03634462

The ClinicalTrials.gov registry entry for NCT03634462 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which CDT with graded negative pressure is the first listed.

NCT03634462 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03634462 about?

NCT03634462 is a clinical study titled "Complete Decongestive Therapy With Negative Pressure for Lipedema and Lymphedema Therapy". This study is designed to investigate the therapy outcomes from routine physical therapy in persons with lipedema and secondary limb lymphedema. Complete decongestive therapy (CDT) is a common conservative treatment to optimize lymphatic functioning using exercise, compression, lymphatic stimulation...

What is the current status of trial NCT03634462?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-01-15. Estimated completion is 2020-02-28.

What interventions are being tested in trial NCT03634462?

The interventions under investigation include: CDT with graded negative pressure (OTHER).

Who is sponsoring clinical trial NCT03634462?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.